Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)

Professor Gregory Lip; Albert L. Waldo; James E. Ip; David T. Martin; Malcolm Bersohn; Wassim Choucair; Joseph G. Akar; Mark S. Wathen; Jonathan L. Halperin

doi:10.1016/j.amjcard.2016.08.047

Related publications

Article2019

Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study

Maria Cristina Vedovati, Maria Giulia Mosconi, Federico Isidori, Giancarlo Agnelli, Cecilia Becattini

Article2025

Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study

Alex Luojus, Mika Lehto, Olli Halminen, Ossi Lehtonen, Mikko Niemi, Konsta Teppo, Jaana Kuoppala, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Aapo L. Aro, Juha Hartikainen, Professor Gregory Lip, Juhani Airaksinen

Article2020

A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke

Manuel Cappellari, David Seiffge, Masatoshi Koga, Maurizio Paciaroni, Stefano Forlivesi, Gianni Turcato, Paolo Bovi, Sohei Yoshimura, Kanta Tanaka, Masayuki Shiozawa, Takeshi Yoshimoto, Kaori Miwa, Masahito Takagi, Manabu Inoue, Hiroshi Yamagami, Valeria Caso, Georgios Tsivgoulis, Michele Venti, Monica Acciarresi, Andrea Alberti, Danilo Toni, Alexandros A. Polymeris, Bruno Bonetti, ,

Article2022

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan

Yi‐Hsin Chan, Tze‐Fan Chao, Shao‐Wei Chen, Hsin‐Fu Lee, Wei-Min Chen, Pei‐Ru Li, Yung‐Hsin Yeh, Chi‐Tai Kuo, Lai‐Chu See, Professor Gregory Lip

Article2024

Risk of incident genitourinary cancer following hematuria in patients with atrial fibrillation receiving oral anticoagulants

Ling Kuo, Yi‐Hsin Chan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen, Tze‐Fan Chao